The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Intracavernous Injection Therapy: Analysis of Results and Complications
Abstract
Experience with 100 patients who used intracavernous injection therapy with a combination of papaverine with or without phentolamine for 29 months is analyzed in detail. The largest group of patients had vasculogenic erectile failure (56%). At the end of followup 50% of the patients were no longer performing injection. Those who discontinued injection therapy were slightly older and had more vasculogenic erectile failure. The nonfibrotic complications were mild in all instances and did not result in discontinuation of injection therapy. These complications consisted of small hematomas in 20.9% of the patients, mild discomfort in 13.6% and mild liver enzyme abnormalities in 9.8%. No episode of priapism or infection occurred during therapy. Fibrotic complications consisted of nodules or plaques, and correlated significantly with the number of months on injection and the number of injections. At 12 months the fibrotic complication rate was 31 +/- 8.6%. Our study suggests caution regarding the long-term complication rate of intracavernous injection therapy with these compounds and underscores the importance of routine followup examinations. While injection therapy is an effective form of treatment for erectile failure, it is not a satisfactory alternative for many patients and is associated with a significant fibrotic complication rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Individual Comparisons by Ranking Methods
Wilcoxon, F. (1945) · Biometrics Bulletin · doi:10.2307/3001968 · Cited by 15,354
Cited by
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation
Hatzimouratidis, K., Amar, E., Eardley, I., Giuliano, F., Hatzichristou, D., Montorsi, F., Vardi, Y., & Wespes, E. (2010) · European Urology · doi:10.1016/j.eururo.2010.02.020 · Cited by 1,223
Erectile dysfunction: AUA guideline
Burnett, A. L., Nehra, A., Breau, R. H., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J., Khera, M., McVary, K. T., Miner, M. M., et al. (2018) · Journal of Urology · doi:10.1016/j.juro.2018.05.004 · Cited by 949
Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil
Padma-Nathan, H., Hellstrom, W. J. G., Kaiser, F. E., Labasky, R. F., Lue, T. F., Nolten, W. E., Norwood, P. C., Peterson, C. A., Shabsigh, R., Tam, P. Y., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701023360101 · Cited by 574
The Rationale for Prostaglandin E1 in Erectile Failure: A Survey of Worldwide Experience
Porst, H. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66315-8 · Cited by 316
A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil
Hellstrom, W. J. G., Bennett, A. H., Gesundheit, N., Kaiser, F. E., Lue, T. F., Padma-Nathan, H., Peterson, C. A., Tam, P. Y., Todd, L. K., Varady, J. C., et al. (1996) · Urology · doi:10.1016/s0090-4295(96)00428-1 · Cited by 76
Metadata
- Authors
- Lakin, M. M., Montague, D. K., Medendorp, S. V., Tesar, L., & Schover, L. R.
- Venue
- Journal of Urology
- Published
- 1990-06
- Volume
- 143
- Issue
- 6
- Pages
- 1138-1141
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W88262059
- Cited by
- 171
- References
- 1
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intracavernous Injection Therapy: Analysis of Results and Complications. https://app.cochat.ai/papers/10.1016/s0022-5347(17)40208-4
- The paper
- Lakin, M. M., Montague, D. K., Medendorp, S. V., Tesar, L., & Schover, L. R. (1990). Intracavernous Injection Therapy: Analysis of Results and Complications. Journal of Urology. https://doi.org/10.1016/s0022-5347(17)40208-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.